Noncoding RNAs in extracellular fluids as cancer biomarkers: the new frontier of liquid biopsies

B Pardini, AA Sabo, G Birolo, GA Calin - Cancers, 2019 - mdpi.com
The last two decades of cancer research have been devoted in two directions:(1)
understanding the mechanism of carcinogenesis for an effective treatment, and (2) …

MiR‐30a: a novel biomarker and potential therapeutic target for cancer

L Jiang, H Zhang, J Tang - Journal of oncology, 2018 - Wiley Online Library
MicroRNAs (miRNAs) are small, highly conserved noncoding RNAs molecules, consisting of
18–25 nucleotides that regulate gene expression by binding to complementary binding sites …

Diagnostic utility of molecular and imaging biomarkers in cytological indeterminate thyroid nodules

EJ de Koster, LF de Geus-Oei, OM Dekkers… - Endocrine …, 2018 - academic.oup.com
Indeterminate thyroid cytology (Bethesda III and IV) corresponds to follicular-patterned
benign and malignant lesions, which are particularly difficult to differentiate on cytology …

MicroRNAs in papillary thyroid cancer: what is new in diagnosis and treatment

M Papaioannou, AG Chorti, A Chatzikyriakidou… - Frontiers in …, 2022 - frontiersin.org
Introduction Papillary thyroid cancer (PTC) accounts for up to 80% of thyroid malignancies.
New diagnostic and therapeutic options are suggested including innovative molecular …

[HTML][HTML] MicroRNA-30a-5p inhibits the growth of renal cell carcinoma by modulating GRP78 expression

C Wang, L Cai, J Liu, G Wang, H Li, X Wang… - Cellular Physiology and …, 2017 - karger.com
Background/Aims: MiR-30a-5p, a member of the microRNA-30 family (miR-30), is known to
function as a tumor suppressor in several different cancers. However, the expression levels …

[HTML][HTML] Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway

B Qi, Y Wang, ZJ Chen, XN Li, Y Qi… - World Journal of …, 2017 - ncbi.nlm.nih.gov
AIM To investigate the potential role of microRNA-30a (miR-30a) in esophageal squamous
cell carcinoma (ESCC). METHODS Expression of miR-30a-3p/5p was analyzed using …

Circulating microRNAs and clinicopathological findings of papillary thyroid cancer: A systematic review

G Geropoulos, K Psarras, M Papaioannou, D Giannis… - in vivo, 2022 - iv.iiarjournals.org
Background/Aim: Papillary thyroid cancer (PTC) is the most common endocrine malignancy
with a rising incidence. There is a need for a non-invasive preoperative test to enable better …

Identification of exosomal and non-exosomal microRNAs associated with the drug resistance of ovarian cancer

Y Feng, W Hang, Z Sang, S Li… - Molecular …, 2019 - spandidos-publications.com
MicroRNAs (miRNAs) serve important roles in drug-resistance; however, exosomal miRNAs
associated with drug-resistance in ovarian cancer (OC) have not been reported to date. The …

Comparison of oncogenes, tumor suppressors, and MicroRNAs between schizophrenia and glioma: the balance of power

JS Brown Jr - Neuroscience & Biobehavioral Reviews, 2023 - Elsevier
The risk of cancer in schizophrenia has been controversial. Confounders of the issue are
cigarette smoking in schizophrenia, and antiproliferative effects of antipsychotic medications …

Expression of MicroRNAs in thyroid carcinoma

G Zhu, L Xie, D Miller - Bioinformatics in MicroRNA Research, 2017 - Springer
MicroRNA (miRNA) are negative regulators of gene expression and subsequent protein
production. This method of action translates into regulatory control over cellular processes …